Abstract
ABSTRACT Objective: To compare the use of drugs to control low back pain in the pre- and postoperative periods among patients with Failed Back Surgery Syndrome (FBSS) undergoing neuromodulation. Methods: Retrospective observational study analyzing the medical records of patients with FBSS who underwent neuromodulation, followed up in an outpatient clinic from 2018 to 2020. The characteristics of the patients were evaluated: the use of medications, quality of life through the results of the Short Form 36 Health Survey Questionnaire (SF-36), and functional capacity using the Oswestry Disability Index (ODI) in the pre-surgical and post-surgical periods (06 months, 01 year). The criterion for establishing statistical significance was p≤0.05. Results: 56 patients were evaluated. There was a reduction in the use of pain control drugs after the institution of neuromodulation, including in the opioid class (d=0.81). An improvement was also observed in the ODI scores (p<0.001) and all the SF-36 domains (p<0.02) in the postoperative periods investigated. Conclusion: The data suggest that neuromodulation positively impacted back pain by reducing medication use and improving functional capacity and quality of life. Level of Evidence IV; Retrospective, Observational Study.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
